RX-1 Rhythm Express Remote Cardiac Monitoring System

The RX-1 Rhythm Express Remote Cardiac Monitoring System is designed for continuous ECG monitoring in adult patients to detect cardiac arrhythmias. Utilizing an embedded algorithm for ECG analysis and cellular technology for data transmission, the device records and forwards cardiac events to a server for physician review, operating in Mobile Cardiac Telemetry, Event Recorder, or Wireless Holter modes.

The RX-1 Rhythm Express Remote Cardiac Monitoring System is designed for adult patients who have, or are at risk of, cardiac disease, or exhibit intermittent symptoms suggesting cardiac issues requiring continuous monitoring. Prescribed by a physician, typically for 1 day to 4 weeks, the device continuously monitors 2-channel ECG data using standard electrodes and operates in one of three modes: Mobile Cardiac Telemetry (MCT), Event Recorder (ER), or Wireless Holter (WH). The system is intended for collecting data for subsequent review by medical professionals, not for real-time alarms or life support. The RX-1 system captures ECG signals, which are then processed by an embedded algorithm capable of detecting arrhythmias, compressing ECG data, and removing most in-band noise without distorting ECG morphology. Upon algorithmic detection or manual patient initiation, the device transmits recorded cardiac activity to the RS-1 Web Service via an integrated cellular modem. Performance testing verified the system's ability to continuously record, store, and transmit ECG data as designed. The system does not deliver therapy, administer drugs, or provide interpretive diagnostic statements; event communication to the monitoring center takes one to seven minutes, contingent on cellular service.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the embedded algorithm's performance in arrhythmia detection and noise removal compare to established gold-standard algorithms, particularly concerning ECG morphology preservation?; What are the specific criteria and thresholds used by the algorithm to auto-detect arrhythmias such as Bradycardia, Tachycardia, and Atrial Fibrillation/Flutter?; Given the 1-7 minute data transmission delay, what protocols are in place for managing potentially critical findings that are not immediately life-threatening but require timely physician review?; What is the impact of the 2-channel ECG system compared to the predicate's 3-lead system on the diagnostic yield and accuracy for various types of arrhythmias?; Could the absence of an accelerometer in the RX-1, unlike its predicate, limit the contextual understanding of ECG events relative to patient activity levels, and how is this addressed in clinical interpretation?